Explore more publications!

Press Releases

Landmark Lancet Study Demonstrates Safety and Efficacy of Magnetic Seizure Therapy in Depression
Europe Faces Energy Shock as Middle East Conflict Escalates

Europe Faces Energy Shock as Middle East Conflict Escalates

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026
Evaxion concludes Annual General Meeting
US to Expanded Army Access in Greenland Amid Talks with Denmark

US to Expanded Army Access in Greenland Amid Talks with Denmark

Voting Kicks Off in Denmark as Closest Election in Years Looms

Voting Kicks Off in Denmark as Closest Election in Years Looms

Groundbreaking Danish research project launches to cure Parkinson’s disease
Delegation Visit to Denmark: Strengthening Dialogue on the Future of Work

Delegation Visit to Denmark: Strengthening Dialogue on the Future of Work

BioVerde and Unibio Partner on Methane-Based Route to Butadiene and Other Chemical Intermediates
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Space Economic Forum 2026 Selects Helsinki Finland as Global Convening Hub for the Future of the Cis-Lunar Space Economy
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure
Major Shareholder Announcement

Major Shareholder Announcement

Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
Leapwork Announces Continuous Validation Platform Designed to Ensure Full Software Quality In Every Application, Environment, and Stage of AI Adoption
FREUDENBERG HAS COMPLETED THE VOLUNTARY PUBLIC TAKEOVER OFFER OF NILFISK HOLDING A/S

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions